Decoding 9 Analyst Evaluations For Axsome Therapeutics
Decoding 9 Analyst Evaluations For Axsome Therapeutics
解碼關於axsome therapeutics的9位分析師評估
Axsome Therapeutics (NASDAQ:AXSM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 3 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 0 | 0 | 0 |
| 3M Ago | 3 | 2 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Axsome Therapeutics, revealing an average target of $129.89, a high estimate of $190.00, and a low estimate of $95.00. Surpassing the previous average price target of $127.11, the current average has increased by 2.19%.
Interpreting Analyst Ratings: A Closer Look
The standing of Axsome Therapeutics among financial experts becomes clear with a...
登入免費觀看全文
登入/註冊